APTO

Aptose Biosciences Inc

NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY

$1.71

+0.00% today

Updated 2026-06-05

Market cap

$4.36M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-36.38

Dividend yield

—

52W range

$0 – $0

Volume

—

Market cap

$4.36M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-36.38

Dividend yield

—

52W range

$0 – $0

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$12.50

+630.99%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-8.06M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-65.35M	$-41.82M	$-51.21M	$-25.43M	$-1.58M
EPS	—	—	—	—	$-36.38
Free cash flow	$-43.52M	$-32.35M	$-44.62M	$-35.98M	$-8.06M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
APTO	$4.36M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Aptose Biosciences Inc trades at $1.71. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Aptose Biosciences Inc's stock price?

Aptose Biosciences Inc (APTO) trades at $1.71.

Is Aptose Biosciences Inc overvalued?

Aptose Biosciences Inc carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Aptose Biosciences Inc (APTO)?

The 12-month analyst consensus target is $12.50, about 631.0% above the current $1.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-694.00%

Beta1.13

50D MA$3.60

200D MA$8.76

Shares out0.00B

Float0.00B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

APTO vs LLY →APTO vs JNJ →APTO vs ABBV →Stock screener →